» Articles » PMID: 28401035

Development and Application of Human Renal Proximal Tubule Epithelial Cells for Assessment of Compound Toxicity

Overview
Publisher Bentham Open
Specialty Genetics
Date 2017 Apr 13
PMID 28401035
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Kidney toxicity is a major problem both in drug development and clinical settings. It is difficult to predict nephrotoxicity in part because of the lack of appropriate cell models, limited endpoints, and the observation that the activity of membrane transporters which plays important roles in nephrotoxicity by affecting the pharmacokinetic profile of drugs is often not taken into account. We developed a new cell model using pseudo-immortalized human primary renal proximal tubule epithelial cells. This cell line (SA7K) was characterized by the presence of proximal tubule cell markers as well as several functional properties, including transporter activity and response to a few well-characterized nephrotoxicants. We subsequently evaluated a group of potential nephrotoxic compounds in SA7K cells and compared them to a commonly used human immortalized kidney cell line (HK-2). Cells were treated with test compounds and three endpoints were analyzed, including cell viability, apoptosis and mitochondrial membrane potential. The results showed that most of the known nephrotoxic compounds could be detected in one or more of these endpoints. There were sensitivity differences in response to several of the chemicals between HK-2 and SA7K cells, which may relate to differences in expressions of key transporters or other components of nephrotoxicity pathways. Our data suggest that SA7K cells appear as promising for the early detection of renal toxicants.

Citing Articles

Insights into Repeated Renal Injury Using RNA-Seq with Two New RPTEC Cell Lines.

Merrick B, Martin N, Brooks A, Foley J, Dunlap P, Ramaiahgari S Int J Mol Sci. 2023; 24(18).

PMID: 37762531 PMC: 10531624. DOI: 10.3390/ijms241814228.


HK-2 cell response to TGF-β highly depends on cell culture medium formulations.

Garmaa G, Manzeger A, Haghighi S, Kokeny G Histochem Cell Biol. 2023; 161(1):69-79.

PMID: 37752256 PMC: 10794419. DOI: 10.1007/s00418-023-02237-x.


Functional Evaluation and Nephrotoxicity Assessment of Human Renal Proximal Tubule Cells on a Chip.

Jing B, Yan L, Li J, Luo P, Ai X, Tu P Biosensors (Basel). 2022; 12(9).

PMID: 36140103 PMC: 9496563. DOI: 10.3390/bios12090718.


Urinary Polycyclic Aromatic Hydrocarbons in a Longitudinal Cohort of Children with CKD: A Case of Reverse Causation?.

Jacobson M, Wu Y, Liu M, Kannan K, Lee S, Ma J Kidney360. 2022; 3(6):1011-1020.

PMID: 35845343 PMC: 9255870. DOI: 10.34067/KID.0000892022.


Intracellular Recording of Cardiomyocytes by Integrated Electrical Signal Recording and Electrical Pulse Regulating System.

Liu Z, Xu D, Fang J, Xia Q, Zhong W, Li H Front Bioeng Biotechnol. 2022; 9:799312.

PMID: 34976989 PMC: 8714743. DOI: 10.3389/fbioe.2021.799312.


References
1.
Anzai N, Jutabha P, Endou H . Molecular mechanism of ochratoxin a transport in the kidney. Toxins (Basel). 2011; 2(6):1381-98. PMC: 3153260. DOI: 10.3390/toxins2061381. View

2.
Markowitz G, Perazella M . Drug-induced renal failure: a focus on tubulointerstitial disease. Clin Chim Acta. 2004; 351(1-2):31-47. DOI: 10.1016/j.cccn.2004.09.005. View

3.
Tiong H, Huang P, Xiong S, Li Y, Vathsala A, Zink D . Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models. Mol Pharm. 2014; 11(7):1933-48. DOI: 10.1021/mp400720w. View

4.
Rangarajan A, Weinberg R . Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice. Nat Rev Cancer. 2004; 3(12):952-9. DOI: 10.1038/nrc1235. View

5.
Bellomo R . The epidemiology of acute renal failure: 1975 versus 2005. Curr Opin Crit Care. 2006; 12(6):557-60. DOI: 10.1097/01.ccx.0000247443.86628.68. View